Patient Blood Management - Use and Outcome

Completed

• Conditions: Hemorrhage

• Registration Number: NCT02473666
• Lead Sponsor: University of Zurich

Brief Summary

Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.

Detailed Description

At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.

Study Timeline

• Study Start: 2012-01
• Study First Submitted: 2015-05-11
• Study First Submitted QC: 2015-06-11
• Study First Posted: 2015-06-16
• Primary Completion: 2019-12
• Study Completion: 2019-12
• Status Verified: 2020-11
• Last Update Submitted: 2020-11-10
• Last Update Posted: 2020-11-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 250000

Inclusion Criteria

• Only case records, all discharged patients of the University Hospital of Zürich

Read More

Exclusion Criteria

• Not discharged from our Hospital.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of transfusions per participant	participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years	Participant wich had transfusion will be identified and the administrative, financial and clinical data will be compared to participants without transfusions

Secondary Outcome Measures

Name	Time	Method
Cost of any blood product per participant	participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years	costs per case
Percentage of transfusion of any blood product per participant	participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years	Count of any blood products per case, QM Data
Survey of Patient Blood Management System	participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years	clinical, financial,and administrative data of all participants will be reviewed on the focus on transfusions

Trial Locations

Locations (1)

University Hospital Zurich; 🇨🇭 Zurich, Switzerland